– Revenue of $1.471 Billion, GAAP Diluted EPS of $1.95, and Non-GAAP Diluted EPS of $2.17 All Significantly Exceed Expectations…
TORONTO, ON / ACCESSWIRE / February 2, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") is pleased to announce…
FT MYERS, FL / ACCESSWIRE / February 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…
Calgary, Alberta--(Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased…
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 2, 2022) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:…
More than 96% of athenaOne® clinicians received positive payment adjustments WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc., a leading provider of network-enabled software…
Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINKJUPITER, FL / ACCESSWIRE / February…
GOTHENBURG, SE / ACCESSWIRE / February 2, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)XVIVO Perfusion AB has gained regulatory…
GOLDEN, CO / ACCESSWIRE / February 2, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,…
Additional Talent Enables the Company to Pursue COVID-19 Testing Accreditation within the Province of British ColumbiaVANCOUVER, BC / ACCESSWIRE /…